BioVaxys Technology ( ($TSE:BIOV) ) just unveiled an announcement. BioVaxys’ 2025 corporate review highlights the integration of the DPX platform ...

Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how advanced artificial intelligence and population health analytics can identify ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

The American Cancer Society’s Report on the Status of Cancer Disparities in the United States examines disparities in cancer occurrence and outcomes, and analyzes the factors that contribute to these ...

Nuvalent has reported phase 1/2 lung cancer data, teeing the biotech up to talk to the FDA about an approval filing that could establish its neladalkib as a challenger to Pfizer’s Lorbrena. The ALKOVE ...

Source: Getty Images Breast cancer is the second most common cancer affecting American women and the second leading cause of cancer death in women. These numbers are higher than estimates from 2023, ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endometrial cancer. The biotech reported a 50% unconfirmed response rate, beating the expectations of William Blair ...

Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...

“1 in 20 Iowans have had a diagnosis of cancer in their lifetime, and if the trends continue, we’re headed towards one in 10.” Dr. Mary Charlton, Director of the Iowa Cancer Registry SIOUX CITY (KTIV) ...

Cancer registrars throughout the world will join their colleagues, fellow medical professionals, and community leaders to observe the 25th annual National Cancer Registrars Week (NCRW), April 5–9, ...

Cancer is becoming a global crisis shaped less by biology than by inequality, risk exposure, and access to care.